Resistance Gene Turns Up in Saudi Arabia Patient

The blaNDM-19 gene on a mobile plasmid reached a patient in Riyadh, a first for the country in published research.

Updated on Nov. 5, 2026 in Life Sciences

Bold flat-color editorial illustration of a glass dish with an amber colony field beside a coiled geometric DNA loop on a deep red and cream background.
Researchers in Saudi Arabia detected a mobile antibiotic-resistance gene, blaNDM-19, in a patient in Riyadh, a first for the country in published research. AI Illustration. Upload story photo >

Researchers reported the first detection in Saudi Arabia of an Escherichia coli isolate carrying the blaNDM-19 carbapenemase gene, which confers resistance to a broad class of antibiotics. The isolate was recovered from a blood sample of a patient at King Fahad Medical City in Riyadh, and the findings are published as accepted peer-reviewed research in Scientific Reports, so this is research-stage reporting rather than a clinical rollout.

Why it matters

The gene sits on a conjugative IncX3 plasmid, a mobile DNA element that can transfer between bacteria, which is why its spread across regions matters. The detection links Saudi Arabia to earlier reports of similar IncX3 plasmids carrying blaNDM-19 in Switzerland, China, Lebanon and Palestine, suggesting a wider geographic circulation of this resistance vehicle.

The evidence is whole genome sequencing of one clinical isolate, designated EC24_NDM-19, classified as sequence type 167 and phylogroup A. The 49.8 kb plasmid contig was assembled from Illumina MiSeq and Oxford Nanopore GridION reads, and the study does not report prevalence beyond this single case.

The players

King Fahad Medical City

A major tertiary hospital in Riyadh, Saudi Arabia, where the patient sample was collected and the isolate was recovered.

Scientific Reports

A peer-reviewed open-access journal published by Nature Portfolio that carries primary research across the natural and life sciences.

The details

Carbapenemases are bacterial enzymes that break down carbapenem antibiotics, often considered last-line drugs. The blaNDM-19 gene encodes one such enzyme and sits on a plasmid, a small circular piece of DNA separate from the bacterial chromosome that can be copied and passed to other bacteria. The plasmid was identified computationally as a conjugative IncX3 type, meaning it carries the machinery to transfer itself between cells, which is how resistance genes spread across species and borders.

Timeline

  1. Specimen recovered from a patient after prostatocystectomy at King Fahad Medical City in Riyadh; exact collection date not reported.

  2. Article published early as accepted peer-reviewed research in Scientific Reports on November 5, 2026.

The Tech Race

The finding places Saudi Arabia alongside Switzerland, China, Lebanon and Palestine in documenting the same IncX3 plasmid-borne blaNDM-19 structure. It adds a geographic data point to a body of surveillance work tracking how carbapenemase genes move on shared plasmid backbones across regions.

This is a research-stage report of one isolate and does not change any current treatment guidance or availability. The practical relevance is for hospital infection-control and laboratory surveillance programs that screen for carbapenemase genes, but no timeline for such changes is given.

The takeaway

The trajectory to watch is whether blaNDM-19 on IncX3 plasmids keeps appearing in new countries, which would show a regional spread pattern. Surveillance reports tracking this gene across the Middle East and beyond will show whether the Saudi Arabian detection is an isolated event or part of wider circulation.

Further reading

For background on how such resistance spreads, see Life Sciences.

Source note: This article includes information reported by Nature.